{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:26:19Z","timestamp":1790724379453,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":195,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"T&P Bohnenn Fund","award":["29-006"],"award-info":[{"award-number":["29-006"]}]},{"name":"Belgian Ministry of Health"},{"name":"FNRS of Belgium"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The antiepileptic drug valproic acid (VPA) inhibits histone deacetylase in glioblastoma cells in vitro, which influences several oncogenic pathways and decreases glioma cell proliferation. The clinical relevance of these observations remains unclear, as VPA does not seem to affect glioblastoma patient survival. In this study, we analyzed whether the in vitro effects of VPA treatment on histone acetylation are also observed in tumor tissues of glioblastoma patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The in vitro effects of VPA treatment on histone acetylation were assessed with immunofluorescence and western blotting. On tissue microarrays and in fresh-frozen glioblastoma tissues we investigated the histone acetylation patterns of patients who were either treated with VPA or did not receive antiepileptic drugs at the time of their surgery. We also performed mRNA expression-based and gene set enrichment analyses on these tissues.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>VPA increased the expression levels of acetylated histones H3 and H4 in vitro, in agreement with previous reports. In tumor samples obtained from glioblastoma patients, however, VPA treatment affected neither gene (set) expression nor histone acetylation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The in vitro effects of VPA on histone acetylation status in glioblastoma cells could not be confirmed in clinical tumor samples of glioblastoma patients using antiepileptic doses of VPA, which reflects the lack of effect of VPA on the clinical outcome of glioblastoma patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/noajnl\/vdz025","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T12:38:38Z","timestamp":1573562318000},"source":"Crossref","is-referenced-by-count":13,"title":["Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples"],"prefix":"10.1093","volume":"1","author":[{"given":"Sharon","family":"Berendsen","sequence":"first","affiliation":[{"name":"Departments of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center of Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elselien","family":"Frijlink","sequence":"first","affiliation":[{"name":"Departments of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center of Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e8r\u00f4me","family":"Kroonen","sequence":"first","affiliation":[{"name":"Departments of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center of Utrecht, Utrecht, The Netherlands"},{"name":"Department of Human Genetics, GIGA Research Center, University of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim G M","family":"Spliet","sequence":"first","affiliation":[{"name":"Department of Pathology, University Medical Center of Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-4219","authenticated-orcid":false,"given":"Wim","family":"van Hecke","sequence":"first","affiliation":[{"name":"Department of Pathology, University Medical Center of Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Seute","sequence":"first","affiliation":[{"name":"Departments of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center of Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J","family":"Snijders","sequence":"first","affiliation":[{"name":"Departments of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center of Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre A","family":"Robe","sequence":"first","affiliation":[{"name":"Departments of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center of Utrecht, Utrecht, The Netherlands"},{"name":"Department of Human Genetics, GIGA Research Center, University of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"issue":"23","key":"2020050521581277800_CIT0001","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"2020050521581277800_CIT0002","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"issue":"7","key":"2020050521581277800_CIT0003","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJMoa1006312","article-title":"NFKBIA deletion in glioblastomas","volume":"364","author":"Bredel","year":"2011","journal-title":"N Engl J Med"},{"issue":"39","key":"2020050521581277800_CIT0004","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"issue":"9","key":"2020050521581277800_CIT0005","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/13543784.2012.694425","article-title":"Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results","volume":"21","author":"Berendsen","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"2020050521581277800_CIT0006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-014-1713-x","article-title":"The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells","volume":"122","author":"Hosein","year":"2015","journal-title":"J Neurooncol"},{"issue":"2","key":"2020050521581277800_CIT0007","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","article-title":"Valproic acid induces p21 and topoisomerase-II (alpha\/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines","volume":"85","author":"Das","year":"2007","journal-title":"J Neurooncol"},{"key":"2020050521581277800_CIT0008","doi-asserted-by":"crossref","first-page":"e1435","DOI":"10.1038\/cddis.2014.412","article-title":"Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe","volume":"5","author":"Cornago","year":"2014","journal-title":"Cell Death Dis"},{"key":"2020050521581277800_CIT0009","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res"},{"key":"2020050521581277800_CIT0010","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","article-title":"The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3","volume":"72","author":"Chen","year":"1999","journal-title":"J. Neurochem"},{"issue":"6","key":"2020050521581277800_CIT0011","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1159\/000447912","article-title":"Valproic acid promotes human glioma U87 cells apoptosis and inhibits glycogen synthase kinase-3beta through ERK\/Akt signaling","volume":"39","author":"Zhang","year":"2016","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"2020050521581277800_CIT0012","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","article-title":"Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma","volume":"34","author":"Happold","year":"2016","journal-title":"J Clin Oncol"},{"issue":"5","key":"2020050521581277800_CIT0013","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/neuonc\/nov238","article-title":"Prognostic relevance of epilepsy at presentation in glioblastoma patients","volume":"18","author":"Berendsen","year":"2016","journal-title":"Neuro Oncol"},{"issue":"1","key":"2020050521581277800_CIT0014","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/cancers11010041","article-title":"Epilepsy associates with decreased HIF-1alpha\/STAT5b signaling in glioblastoma","volume":"11","author":"Berendsen","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"2020050521581277800_CIT0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11060-008-9794-z","article-title":"Epilepsy in glioblastoma multiforme: correlation with glutamine synthetase levels","volume":"93","author":"Rosati","year":"2009","journal-title":"J Neurooncol"},{"issue":"5","key":"2020050521581277800_CIT0016","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/neuonc\/nos338","article-title":"Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme","volume":"15","author":"Rosati","year":"2013","journal-title":"Neuro Oncol"},{"issue":"10","key":"2020050521581277800_CIT0017","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.seizure.2013.08.004","article-title":"Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control","volume":"22","author":"Yuan","year":"2013","journal-title":"Seizure"},{"key":"2020050521581277800_CIT0018","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/1471-2105-7-526","article-title":"Chromosomal patterns of gene expression from microarray data: methodology, validation and clinical relevance in gliomas","volume":"7","author":"Turkheimer","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"43","key":"2020050521581277800_CIT0019","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U.S.A."},{"issue":"5","key":"2020050521581277800_CIT0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat genet"},{"issue":"1","key":"2020050521581277800_CIT0021","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"10","key":"2020050521581277800_CIT0022","doi-asserted-by":"crossref","first-page":"e46425","DOI":"10.1371\/journal.pone.0046425","article-title":"In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrow","volume":"7","author":"Wislet-Gendebien","year":"2012","journal-title":"PLos One"},{"issue":"25","key":"2020050521581277800_CIT0023","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U.S.A."},{"issue":"16","key":"2020050521581277800_CIT0024","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1158\/1078-0432.CCR-03-0392","article-title":"In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas","volume":"10","author":"Robe","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2020050521581277800_CIT0025","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ijc.25709","article-title":"Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection","volume":"129","author":"Kroonen","year":"2011","journal-title":"Int J Cancer"},{"issue":"24","key":"2020050521581277800_CIT0026","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"issue":"4","key":"2020050521581277800_CIT0027","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.neuroscience.2008.07.065","article-title":"Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression","volume":"156","author":"Ben\u00edtez","year":"2008","journal-title":"Neuroscience"},{"issue":"7","key":"2020050521581277800_CIT0028","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","article-title":"The activity of antiepileptic drugs as histone deacetylase inhibitors","volume":"45","author":"Eyal","year":"2004","journal-title":"Epilepsia"},{"issue":"9","key":"2020050521581277800_CIT0029","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jpsychires.2013.05.028","article-title":"Antidepressants and mood stabilizers effects on histone deacetylase expression in C57BL\/6 mice: brain region specific changes","volume":"47","author":"Ookubo","year":"2013","journal-title":"J Psychiatr Res"},{"key":"2020050521581277800_CIT0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2014.06.023","article-title":"A physiologically based pharmacokinetic model for valproic acid in adults and children","volume":"63","author":"Ogungbenro","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"2020050521581277800_CIT0031","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fncel.2014.00418","article-title":"Gliomas and the vascular fragility of the blood brain barrier","volume":"8","author":"Dubois","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"2020050521581277800_CIT0032","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10072-006-0708-6","article-title":"Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group","volume":"27","author":"Riva","year":"2006","journal-title":"Neurol Sci."},{"issue":"2","key":"2020050521581277800_CIT0033","doi-asserted-by":"crossref","first-page":"e0189267","DOI":"10.1371\/journal.pone.0189267","article-title":"The effect of histone deacetylase inhibitors on AHSP expression","volume":"13","author":"Okhovat","year":"2018","journal-title":"PLos One"}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/noa\/article-pdf\/1\/1\/vdz025\/33171753\/vdz025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/noa\/article-pdf\/1\/1\/vdz025\/33171753\/vdz025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T02:10:11Z","timestamp":1588731011000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdz025\/5622885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdz025","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2019,5,1]]},"article-number":"vdz025"}}